in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Actavis Expands into New Markets; May Enter Biosimilars
8:29 AM MDT | October 30, 2009 | Deepti Ramesh in Madrid
Generic pharmaceuticals producer Actavis (Hafnarfjordur, Iceland) says it is expanding its presence in regions such as Japan, the Mideast, and South America. The company is also monitoring closely the biosimilars market and related activities within the sector. Actavis, which is not currently involved in the biosimilars business, is considering entering the market by establishing joint ventures or partnerships, Stefan Sveinsson, executive v.p./R&D at Actavis, told CW at the CPhI expo, held last month in Madrid. Actavis says that biosimilars will play a major...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: